As of September 2024, Medigen Biotechnology has a market cap of $163.87M. This makes Medigen Biotechnology the world's 18600th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $179.28M | -7.81% |
2023 | $194.48M | 33.33% |
2022 | $145.86M | -41.46% |
2021 | $249.17M | -3.04% |
2020 | $256.99M | -4.67% |
2019 | $269.58M | 37.85% |
2018 | $195.56M | 27.26% |
2017 | $153.67M | -55.36% |
2016 | $344.24M | -7.25% |
2015 | $371.16M | -48.65% |
2014 | $722.78M | -16.33% |
2013 | $863.86M | 29.10% |
2012 | $669.14M | 306.16% |
2011 | $164.75M | 155.48% |
2010 | $64.49M | 0.00% |
2009 | $64.49M | -7.19% |
2008 | $69.48M | -60.98% |
2007 | $178.06M | - |